| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technology Officer & EVP | Chief Technology Officer | See Remarks +1 more
1 company
John G. Aunins last filed a Form 4 in January 2020, as Chief Technology Officer & EVP at MCRB. From June 2015 to January 2020, the filings on record show 0 open-market purchases and 16 sales. John G. Aunins's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 105,250 shares of MCRB. The MCRB filings lean toward selling, a net 211,340 shares.
Shares as reported in the last Form 4 for each company; the most recent is from January 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer & EVP | Sell | 9,250 | $35.00 | $323,750.00 | -4.4% | |
| Jul 25, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer & EVP | Sale+OE | 9,390 | $34.18 | $320,950.20 | -4.3% | |
| Jun 27, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer & EVP | Sell | 9,390 | $27.23 | $255,689.70 | -22.3% | |
| May 31, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer & EVP | Sell | 14,015 | $30.05 | $421,087.80 | -25.0% | |
| Apr 25, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer & EVP | Sell | 18,640 | $31.94 | $595,361.60 | -25.0% | |
| Mar 28, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer & EVP | Sell | 9,390 | $23.89 | $224,327.10 | -11.2% |